Table 1

Subgroup analyses for the primary efficacy outcome of modified Rankin Scale 0–2 at 3 months

SubgroupsNumber of studiesNumber of participantsRR (95% CI)Between-study heterogeneityBetween-subgroup heterogeneity
Cochrane's Q statisticp ValueI2 statistic, %Cochrane's Q statisticp ValueI2 statistic, %
Predominant ethnicity1.040.313.9
 Caucasian1215011.80 (1.56 to 2.07)11.090.441
 Asian75032.49 (1.35 to 4.58)23.59<0.00175
Mean (or median) age1.680.1940.6
 ≤65 years98182.39 (1.56 to 3.64)19.610.0159
 >65 years1011861.76 (1.49 to 2.10)11.930.2225
Sex2.370.1257.7
 Male ≤50%56292.49 (1.72 to 3.61)9.880.0460
 Male >50%1312151.77 (1.41 to 2.22)18.640.1036
Median (or mean) baseline NIHSS0.990.320
 ≤588682.18 (1.54 to 3.08)16.150.0257
 >151011081.78 (1.46 to 2.17)13.190.1532
Mode of endovascular treatment18.00<0.00188.9
 IA thrombolysis31584.45 (2.76 to 7.18)0.840.660
 Mechanical therapies21363.23 (1.46 to 7.16)1.100.299
 IA thrombolysis+mechanical therapies1417101.64 (1.44 to 1.86)11.380.580
Imaging methods for collateral grading11.140.0173.1
 ASITN/SIR collateral grading by DSA810171.68 (1.44 to 1.96)7.220.413
 Other grading methods by DSA66682.26 (1.38 to 3.69)11.040.0555
 CT angiography42442.31 (1.07 to 4.96)6.650.0855
 Perfusion CT1754.67 (2.52 to 8.64)Not applicable
Anterior or posterior circulation stroke2.150.347
 Anterior circulation stroke only1411042.24 (1.70 to 2.94)28.380.00854
 Posterior circulation stroke only11241.62 (1.03 to 2.55)Not applicable
 Anterior and posterior circulation strokes47761.74 (1.29 to 2.36)5.360.1544
Intracranial or extracranial arterial occlusion2.660.1062.4
 Intracranial only97382.48 (1.69 to 3.63)19.560.0159
 Extracranial only00Not applicableNot applicable
 Both or tandem lesions1012661.74 (1.44 to 2.10)12.240.2026
  • ASITN/SIR, the American Society of Intervention and Therapeutic Neuroradiology/Society of Interventional Radiology; DSA, digital subtraction angiography; IA, intra-arterial; NIHSS, National Institutes of Health Stroke Scale; RR, risk ratio.